OMEICOS Therapeutics

Health Care, Medical, Therapeutics
Founded in 2013-01-01
Berlin, Berlin, Germany
http://www.omeicos.com/
For Profit

About OMEICOS Therapeutics

OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activate an endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 10 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 37310346 USD
  • Last Funding: 17000000 EUR (Series C)
  • Funding Status: Late Stage Venture

Technology Stack

OMEICOS Therapeutics actively uses 10 products in their tech stack.

Market Presence

Industries: Health Care, Medical, Therapeutics

Headquarters: Berlin, Berlin, Germany